| abstract |
Disclosed is a novel compound having an NPY Y5 receptor antagonistic activity. nA compound represented by the formula:n na pharmaceutically acceptable salt or solvate thereof, nwherein nR 1 is optionally substituted lower alkyl or the like, nR 2 and R 8 are each independently hydrogen or lower alkyl, nX is optionally substituted lower alkylene or the like, nY is -OCONR 7 - or the like, nR 7 is hydrogen, lower alkyl or the like, nZ is optionally substituted carbocyclyl or the like, nW is optionally substituted alkylene or the like. |